Nicola Borsellino

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

Giuseppe Colucci, Vittorio Gebbia, G Paoletti et al. · Journal of Clinical Oncology · 2005 · 775 citations

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial

Domenico Galetta, Saverio Cinieri, Salvatore Pisconti et al. · Clinical Lung Cancer · 2014 · 77 citations · Full text

Maintenance Bevacizumab, Medicine, Metronomic Therapy +7

Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study.

Vittorio Gebbia, A. C. Testa, Nicola Borsellino et al. · PubMed · 1999 · 68 citations

Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy

Vittorio Gebbia, Ignazio Carreca, Antonio Testa et al. · Anti-Cancer Drugs · 1993 · 59 citations

Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.

Antônio Rossi, Cesare Gridelli, Vittorio Gebbia et al. · PubMed · 2003 · 34 citations